🔎 Trials Near Me

Beranda › Karsinoma Epitel Ovarium › Tennessee

Uji klinis Karsinoma Epitel Ovarium di Tennessee

6 studi untuk Karsinoma Epitel Ovarium mencari peserta di lokasi di Tennessee.

Kota di Tennessee

Teks studi resmi (Bahasa Inggris)

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Erlanger Health, Chattanooga
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 5 Okt 2026 · NCT06915025

Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer

  • University of Tennessee Medical Center - Knoxville, Knoxville
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 17 Agu 2026 · NCT07764133

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  • Research Site, Germantown
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 21 Jul 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Sarah Cannon Research Institute (Oncology Associates of Oregon PC), Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Jul 2026 · NCT06819007

CT-95 in Advanced Cancers Associated With Mesothelin Expression

  • Context Investigational Site, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06756035

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.